An interventional study of Experimental and Control in Periodontitis, Obstructive Sleep Apnea and OSAS, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-28.
Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Treatment
The main objective of this study is to compare the effect of the non-surgical periodontal treatment on serum and saliva oxidative stress parameters in patients with periodontitis and obstructive sleep apnea syndrome (OSAS) and in patients with periodontitis only.
There is evidence supporting that OSAS is an independent risk factor for cardiovascular and cerebrovascular diseases such as hypertension, congestive heart failure, myocardial infarction, cardiac-arrhythmia, and stroke.Gender, age, smoking, obesity and diabetes, which are risk factors for periodontitis,It is also common in OSAS at the same time.In addition to common risk factors, both OSAS and periodontitis have been shown to be associated with increased oxidative stress markers.
The investigators aimed to investigate whether non-surgical periodontal treatment on serum and saliva oxidative stress parameters in patients with periodontitis and obstructive sleep apnea syndrome (OSAS) and in patients with periodontitis only.
Exclusion Criteria:
Non-surgical periodontal therapy consisted of scaling and root planing and supportive periodontal therapy during 3 months Individuals: with both OSAS and periodontitis Intervention: Procedure: Non-surgical periodontal therapy
Other: Experimental
Non-surgical periodontal therapy consisted of scaling and root planing and supportive periodontal therapy during 3 months Individuals: only periodontitis Intervention: Procedure: Non-surgical periodontal therapy
Other: Control
Experimental: Non-surgical periodontal therapy in patient with OSAS and Periodontitis
Control: Non-surgical periodontal therapy in Periodontitis
Serum Total Antioxidant Status (TAS) level (millimolar per liter (mmol /L))
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Serum Total Oxidant Status (TOS) level (mikromolar per liter (µmol /L))
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Serum Oxidative Stress Index (OSI) level : TOS/TAS
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Serum Native Thiol (mikromolar per liter (µmol /L))
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Serum Thiol/disulfid (millimolar per liter (mmol /L))
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Saliva Total Antioxidant Status (TAS) level (millimolar per liter (mmol /L))
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Saliva Total Oxidant Status (TOS) level (mikromolar per liter (µmol /L))
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Saliva Oxidative Stress Index (OSI) level : TOS/TAS
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Saliva Native Thiol (mikromolar per liter (µmol /L))
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Saliva Thiol/disulfid (millimolar per liter (mmol /L))
Changes in serum and salivary oxidative stress parameters
Time frame: 3 months
Plaque Index (PI)
Change in clinical measures of chronic periodontitis
Time frame: 3 months
Gingival Index (GI)
Change in clinical measures of chronic periodontitis
Time frame: 3 months
Bleeding on probing (BOP)
Change in clinical measures of chronic periodontitis
Time frame: 3 months
Clinical attachment loss(CAL)
Change in clinical measures of chronic periodontitis
Time frame: 3 months
Probing pocket depth (PD)
Change in clinical measures of chronic periodontitis
Time frame: 3 months
Plan to share: No
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bezmialem Vakif University